Related references
Note: Only part of the references are listed.Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2016)
Innate-like T cell profile in myeloma: Severe deficiency of Vγ9Vδ2 T cells in aminobisphosphonate-treated patients
Mairead Walsh et al.
LEUKEMIA & LYMPHOMA (2016)
Targeting Cancer Cells with a Bisphosphonate Prodrug
Kenji Matsumoto et al.
CHEMMEDCHEM (2016)
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
Heleen H. Van Acker et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Prospects for gene-engineered T cell immunotherapy for solid cancers
Christopher A. Klebanoff et al.
NATURE MEDICINE (2016)
Reprogramming the tumor microenvironment to enhance adoptive cellular therapy
Paul A. Beavis et al.
SEMINARS IN IMMUNOLOGY (2016)
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2016)
The bisphosphonate zoledronic acid effectively targets lung cancer cells by inhibition of protein prenylation
Fan Xie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
Soranobu Ninomiya et al.
BLOOD (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy
Karolina Pilipow et al.
CANCER RESEARCH (2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression
Paul A. Beavis et al.
IMMUNOTHERAPY (2015)
Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2015)
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Rikke B. Holmgaard et al.
CELL REPORTS (2015)
Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity
Daniel Gonnermann et al.
ONCOIMMUNOLOGY (2015)
Blockade of PD-1/PD-L1 Promotes Adoptive T-Cell Immunotherapy in a Tolerogenic Environment
Stephen J. P. Blake et al.
PLOS ONE (2015)
Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies
Drew C. Deniger et al.
CLINICAL CANCER RESEARCH (2014)
Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor-Transduced Human T cells in Solid Tumors
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2014)
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
Andrew Sandstrom et al.
IMMUNITY (2014)
Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid
Ana C. Parente-Pereira et al.
JOURNAL OF IMMUNOLOGY (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Ikuo Wada et al.
CANCER MEDICINE (2014)
Clinical applications of gamma delta T cells with multivalent immunity
Drew C. Deniger et al.
FRONTIERS IN IMMUNOLOGY (2014)
gamma delta T cells for cancer immunotherapy A systematic review of clinical trials
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2014)
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment
Stefani Spranger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
Nicoletta Cieri et al.
BLOOD (2013)
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells
Julie Gertner-Dardenne et al.
BLOOD (2013)
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes
Daniel Abate-Daga et al.
BLOOD (2013)
Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells
Tomoharu Sugie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
Liza B. John et al.
CLINICAL CANCER RESEARCH (2013)
Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
Takamichi Izumi et al.
CYTOTHERAPY (2013)
Can peripheral blood γδ T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy
Shirin Kalyan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Regulation of mTORC1 and its impact on gene expression at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2013)
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity
Hilary Shmeeda et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
Rikke B. Holmgaard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Essential Requirements of Zoledronate-Induced Cytokine and gamma delta T Cell Proliferative Responses
Oliver Nussbaumer et al.
JOURNAL OF IMMUNOLOGY (2013)
Repeated Systemic Administrations of Both Aminobisphosphonates and Human Vγ9Vδ2 T Cells Efficiently Control Tumor Development In Vivo
Thibault Santolaria et al.
JOURNAL OF IMMUNOLOGY (2013)
Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human V gamma 2V delta 2 T Cells
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
Stefano Vavassori et al.
NATURE IMMUNOLOGY (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis
Yonghui Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors
Daniel V. Correia et al.
ONCOIMMUNOLOGY (2013)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines
Weiyi Peng et al.
CANCER RESEARCH (2012)
Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies
Jianhua Zhou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
IL-21 enhances the potential of human γδ T cells to provide B-cell help
Raj R. Bansal et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: Implications for immunotherapy
Vincent Lavoue et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies
Aparna Palakodeti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Regulating Mammalian Target of Rapamycin To Tune Vaccination-Induced CD8+ T Cell Responses for Tumor Immunity
Qingsheng Li et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
Volker Kunzmann et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro
Haishan Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity In Vivo
Ismahene Benzaid et al.
CANCER RESEARCH (2011)
Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
Christopher A. Klebanoff et al.
CLINICAL CANCER RESEARCH (2011)
Zoledronate-activated V gamma 9 gamma delta T cell-based immunotherapy is feasible and restores the impairment of gamma delta T cells in patients with solid tumors
Atsutaka Noguchi et al.
CYTOTHERAPY (2011)
Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens
Masashi Iwasaki et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Involvement of CD56brightCD11c+ Cells in IL-18-Mediated Expansion of Human γδ T Cells
Junko Tsuda et al.
JOURNAL OF IMMUNOLOGY (2011)
Indirect Stimulation of Human Vγ2Vδ2 T Cells through Alterations in Isoprenoid Metabolism
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2011)
The Basis of Distinctive IL-2-and IL-15-Dependent Signaling: Weak CD122-Dependent Signaling Favors CD8+ T Central-Memory Cell Survival but Not T Effector-Memory Cell Development
Iris Castro et al.
JOURNAL OF IMMUNOLOGY (2011)
Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study
Miki Sakamoto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Lipophilic Pyridinium Bisphosphonates: Potent gamma delta T Cell Stimulators
Yonghui Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
Ludovic Martinet et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Xiangdong Liu et al.
BLOOD (2010)
IL-7+IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo
Esther Cha et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients
Florian Cabillic et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Adoptive immunotherapy of cancer using ex vivo expanded human γδ T cells: A new approach
Pouneh Dokouhaki et al.
CANCER LETTERS (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin
Rajesh R. Rao et al.
IMMUNITY (2010)
Cytokine Requirements for the Differentiation and Expansion of IL-17A-and IL-22-Producing Human Vγ2Vδ2 T Cells
Kristin J. Ness-Schwickerath et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-21 preferentially enhances IL-15-mediated homeostatic proliferation of human CD28(+) CD8 memory T cells throughout the adult age span
Huy Nguyen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Peripheral blood monocytes are responsible for gamma delta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
Anke J. Roelofs et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro
Johanna Raikkonen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Adoptive immunotherapy of lung cancer with immobilized anti-TCRγδ antibody-expanded human γδ T-cells in peripheral blood
Ning Kang et al.
CANCER BIOLOGY & THERAPY (2009)
Phenotypic and functional alterations of Vγ2Vδ2 T cell subsets in patients with active nasopharyngeal carcinoma
Kia Joo Puan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Impact of culture medium on the expansion of T cells for immunotherapy
Keisuke Sato et al.
CYTOTHERAPY (2009)
A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells
Ludovic Martinet et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
Yu Abe et al.
EXPERIMENTAL HEMATOLOGY (2009)
IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy
Aurelie Thedrez et al.
JOURNAL OF IMMUNOLOGY (2009)
Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation
Yonghui Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
Christian S. Hinrichs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2008)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Zoledronate facilitates large-scale ex vivo expansion of functional gamma delta T cells from cancer patients for use in adoptive immunotherapy
M. Kondo et al.
CYTOTHERAPY (2008)
Efficacy of IL-2-versus IL-15-stimulated CD8 T cells in adoptive immunotherapy
Katja Mueller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Design, Synthesis, and Biological Evaluation of Novel Aminobisphosphonates Possessing an in Vivo Antitumor Activity Through a γδ-T Lymphocytes-Mediated Activation Mechanism
Danicle Simoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
V gamma 9V delta 2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas
Francoise Bouet-Toussaint et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Zoledronic acid-induced IPP/ApppI production in vivo
Hannu Monkkonen et al.
LIFE SCIENCES (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Distinct cytokine-driven responses of activated blood γδ T cells:: Insights into unconventional T cell pleiotropy
David Vermijlen et al.
JOURNAL OF IMMUNOLOGY (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells:: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens
Craig T. Morita et al.
IMMUNOLOGICAL REVIEWS (2007)
Gamma interferon secretion by human Vγ2Vδ2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-like receptor 2 agonist Pam3Cys
Carl O. Deetz et al.
INFECTION AND IMMUNITY (2006)
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis
K Thompson et al.
MOLECULAR PHARMACOLOGY (2006)
Comparison of common γ-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy
S Liu et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs
Jean-Michel Rondeau et al.
CHEMMEDCHEM (2006)
A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates
H Mönkkönen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Optimum in vitro expansion of human antigen-specific CD8+ T cells for adoptive transfer therapy
M Montes et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
In vivo immunomanipulation of Vγ9Vδ2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model
H Sicard et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells
NL Alves et al.
JOURNAL OF IMMUNOLOGY (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Ex vivo expanded human Vγ9Vδ2+γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro
ZY Liu et al.
JOURNAL OF UROLOGY (2005)
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
R Zeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques
F Villinger et al.
VACCINE (2004)
IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity:: Comparative evaluation of IL-2, IL-15, and IL-21
A Moroz et al.
JOURNAL OF IMMUNOLOGY (2004)
Characterization of tumor reactivity of human Vγ9Vδ2 yδ T cells in vitro and in SCID mice in vivo
D Kabelitz et al.
JOURNAL OF IMMUNOLOGY (2004)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells
EM van Leeuwen et al.
JOURNAL OF IMMUNOLOGY (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Vγ2Vδ2 T-cell receptor-mediated recognition of aminobisphosphonates
H Das et al.
BLOOD (2001)
Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human γδ T cells by aminobisphosphonate antigen
F Miyagawa et al.
JOURNAL OF IMMUNOLOGY (2001)
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis
ME Sheehy et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Distinct tumour specificity and IL-7 requirements of CD56(-) and CD56(+) subsets of human gamma delta T cells
B Zheng et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Share Paper
